Victoria Baltrus Sells 958 Shares of Oscar Health (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) CAO Victoria Baltrus sold 958 shares of the firm’s stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $31.45, for a total value of $30,129.10. Following the completion of the sale, the chief accounting officer directly owned 213,631 shares in the company, valued at $6,718,694.95. This trade represents a 0.45% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Stock Down 4.1%

Shares of OSCR stock opened at $31.64 on Thursday. Oscar Health, Inc. has a 12 month low of $10.69 and a 12 month high of $33.55. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.21. The firm has a market cap of $9.77 billion, a PE ratio of 22.60, a price-to-earnings-growth ratio of 0.68 and a beta of 2.37. The stock has a 50 day moving average of $30.58 and a 200-day moving average of $23.14.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Thursday, August 6th. The company reported $1.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.70. Oscar Health had a net margin of 3.60% and a return on equity of 38.45%. The business had revenue of $4.88 billion for the quarter, compared to the consensus estimate of $4.73 billion. During the same quarter last year, the company posted ($0.89) earnings per share. Oscar Health’s quarterly revenue was up 70.4% on a year-over-year basis. On average, equities analysts predict that Oscar Health, Inc. will post 1.54 EPS for the current year.

Hedge Funds Weigh In On Oscar Health

A number of hedge funds and other institutional investors have recently made changes to their positions in OSCR. Jones Financial Companies Lllp increased its stake in Oscar Health by 7,473.3% in the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after acquiring an additional 2,242 shares during the period. Strs Ohio bought a new position in Oscar Health during the first quarter worth about $30,000. Fifth Third Bancorp boosted its holdings in Oscar Health by 148.7% during the fourth quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock valued at $34,000 after purchasing an additional 1,413 shares in the last quarter. CoreCap Advisors LLC boosted its holdings in Oscar Health by 526.3% during the second quarter. CoreCap Advisors LLC now owns 1,190 shares of the company’s stock valued at $34,000 after purchasing an additional 1,000 shares in the last quarter. Finally, Quarry LP grew its stake in shares of Oscar Health by 439.8% in the 3rd quarter. Quarry LP now owns 1,803 shares of the company’s stock valued at $34,000 after purchasing an additional 1,469 shares during the period. 75.70% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

OSCR has been the topic of several research reports. Barclays boosted their price objective on shares of Oscar Health from $35.00 to $39.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. Zacks Research upgraded Oscar Health from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 6th. Robert W. Baird set a $27.00 price target on Oscar Health in a report on Friday, August 7th. Wall Street Zen upgraded Oscar Health from a “buy” rating to a “strong-buy” rating in a research report on Sunday, June 14th. Finally, Piper Sandler reissued an “overweight” rating and set a $36.00 price objective on shares of Oscar Health in a report on Tuesday, July 28th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $26.22.

Key Stories Impacting Oscar Health

Here are the key news stories impacting Oscar Health this week:

• Positive Sentiment: A recent outlook article argues that Oscar Health’s future remains bright, supported by its technology-driven insurance platform, expanding membership opportunities and potential for continued earnings growth. The future looks bright for Oscar Health stock
• Positive Sentiment: The company’s latest quarterly results were substantially better than expected: earnings per share came in at $1.10 versus the $0.40 consensus estimate, while revenue rose 70.4% year over year to $4.88 billion. Analysts expect full-year EPS of approximately $1.54.
• Positive Sentiment: Institutional ownership remains high at approximately 75.7%, and several funds increased their Oscar Health holdings during the second quarter. Analyst sentiment has also improved in some cases, including a Zacks Research upgrade to “strong buy.”
• Neutral Sentiment: Oscar Health’s chief accounting officer Victoria Baltrus sold 958 shares for $30,129 under a pre-arranged Rule 10b5-1 plan. The filing said the sale covered tax withholding tied to vested equity awards; she retained 213,631 shares. Oscar Health CAO stock sale
• Neutral Sentiment: Director Mario Schlosser, CFO Richard Blackley, Adam Mcananey and Janet Liang also reported stock sales totaling roughly $2.5 million. Each transaction was conducted under a 10b5-1 plan and attributed to tax obligations, while all sellers retained sizable positions.
• Negative Sentiment: The cluster of insider selling may nevertheless weigh on sentiment, particularly because the transactions occurred near OSCR’s 52-week high. The stock’s average analyst rating remains “hold,” with a consensus price target of $26.22, below recent trading levels.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.